Highly active antiretroviral therapy; cardiovascular risk needs to be assessed before starting treatment [editorial]

F Moerman; A Van Gompel; J Nimmegeers; J Moerman

doi:10.1136/bmj.330.7504.1341

Highly active antiretroviral therapy; cardiovascular risk needs to be assessed before starting treatment [editorial]

F Moerman, A Van Gompel, J Nimmegeers, J Moerman

Institute of Tropical Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Journal	BMJ
Volume	330
Issue number	7504
Pages (from-to)	1341-1342
ISSN	0959-8146
DOIs	https://doi.org/10.1136/bmj.330.7504.1341
Publication status	Published - 2005

Keywords

B780-tropical-medicine
Viral diseases
HIV
AIDS
Antiretrovirals
HAART
Adverse effects
Cardiovascular diseases
Risk assessment

Access to Document

10.1136/bmj.330.7504.1341

http://lib.itg.be/pdf/itg/2005/2005bmjo1341.pdf

Cite this

@article{747ca066ccc9401b99f85fb910568406,

title = "Highly active antiretroviral therapy; cardiovascular risk needs to be assessed before starting treatment [editorial]",

keywords = "B780-tropical-medicine, Viral diseases, HIV, AIDS, Antiretrovirals, HAART, Adverse effects, Cardiovascular diseases, Risk assessment",

author = "F Moerman and {Van Gompel}, A and J Nimmegeers and J Moerman",

note = "ITG-C1A; ITG-C2A; CLINIC; U-HIVCLI; U-TROPIC; JIF; DOI; PDF; Reprints-R",

year = "2005",

doi = "10.1136/bmj.330.7504.1341",

language = "English",

volume = "330",

pages = "1341--1342",

journal = "BMJ",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

number = "7504",

}

TY - JOUR

T1 - Highly active antiretroviral therapy; cardiovascular risk needs to be assessed before starting treatment [editorial]

AU - Moerman, F

AU - Van Gompel, A

AU - Nimmegeers, J

AU - Moerman, J

N1 - ITG-C1A; ITG-C2A; CLINIC; U-HIVCLI; U-TROPIC; JIF; DOI; PDF; Reprints-R

PY - 2005

Y1 - 2005

KW - B780-tropical-medicine

KW - Viral diseases

KW - HIV

KW - AIDS

KW - Antiretrovirals

KW - HAART

KW - Adverse effects

KW - Cardiovascular diseases

KW - Risk assessment

U2 - 10.1136/bmj.330.7504.1341

DO - 10.1136/bmj.330.7504.1341

M3 - Editorial

SN - 0959-8146

VL - 330

SP - 1341

EP - 1342

JO - BMJ

JF - BMJ

IS - 7504

ER -